HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scott C Wise Selected Research

DCC-2036

5/2011The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profile.
4/2011Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Scott C Wise Research Topics

Disease

5Neoplasms (Cancer)
11/2021 - 05/2015
3Neoplasm Metastasis (Metastasis)
11/2021 - 09/2015
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017 - 04/2011
1Giant Cell Tumors (Giant Cell Tumor)
11/2021
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2019
1Breast Neoplasms (Breast Cancer)
11/2017
1Carcinoma (Carcinomatosis)
11/2017
1Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2017
1Sickle Cell Anemia (Hemoglobin S Disease)
06/2017
1Necrosis
06/2017
1Fever (Fevers)
06/2017
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017
1Brain Neoplasms (Brain Tumor)
09/2015
1Melanoma (Melanoma, Malignant)
05/2015
1Leukemia
04/2011
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2011

Drug/Important Bio-Agent (IBA)

6Phosphotransferases (Kinase)IBA
01/2019 - 04/2011
2rebastinibIBA
11/2017 - 01/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017 - 09/2015
2Tyrosine Kinase InhibitorsIBA
01/2017 - 04/2011
2DCC-2036IBA
05/2011 - 04/2011
1Macrophage Colony-Stimulating FactorIBA
11/2021
1Biomarkers (Surrogate Marker)IBA
11/2021
1AntibodiesIBA
11/2021
1pexidartinibIBA
11/2021
1Pharmaceutical PreparationsIBA
01/2019
1ripretinibIBA
01/2019
1eribulinFDA Link
11/2017
1Paclitaxel (Taxol)FDA LinkGeneric
11/2017
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2017
1AngiopoietinsIBA
11/2017
1CreatinineIBA
06/2017
1Oxidoreductases (Dehydrogenase)IBA
06/2017
1PotassiumIBA
06/2017
1Lactic Acid (Lactate)FDA LinkGeneric
06/2017
1Adenosine (Adenocard)FDA LinkGeneric
01/2017
1VemurafenibIBA
05/2015
1Urea (Carbamide)FDA LinkGeneric
05/2015
1dabrafenibIBA
05/2015
1LY3009120IBA
05/2015

Therapy/Procedure

3Therapeutics
11/2021 - 05/2011
1Drug Therapy (Chemotherapy)
11/2017
1Hip Replacement Arthroplasty (Total Hip Replacement)
06/2017
1Oral Administration
09/2015